Skip to content
Lower risk Medical device recall · FDA · Published January 8, 2021

Cairn Diagnostics GEBT Test May Give False Negative Gastroparesis Diagnosis

Cairn Diagnostics recalls 13C-Spirulina Gastr: 13C-Spirulina Gastric Emptying Breath Test kits with lot codes K021-021R and K021-022 may cause false negative results for gastroparesis diagnosis.

🇺🇸 FDA recall #Z-1128-2021Medical deviceCairn Diagnostics ›
Take action

Contact the company

Recalling firmCairn Diagnostics105 Westpark Dr Ste 150 · Brentwood, TN 37027-1012
✎ GovInfoNow plain-language explainer

Cairn Diagnostics is recalling specific 13C-Spirulina Gastric Emptying Breath Test kits that could give false negative results for gastroparesis diagnosis. This means the test might miss a serious digestive condition, leading to delayed treatment. Read more at govinfonow.com/recall/63440-cairn-diagnostics-gebt-test-may-give-false-negative-gastroparesis-diagnosis.

Source Summary by GovInfoNow · govinfonow.com/recall/63440-cairn-diagnostics-gebt-test-may-give-false-negative-gastroparesis-diagnosis · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1128-2021

Cite this page

“Cairn Diagnostics GEBT Test May Give False Negative Gastroparesis Diagnosis.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63440-cairn-diagnostics-gebt-test-may-give-false-negative-gastroparesis-diagnosis. Based on FDA recall #Z-1128-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1128-2021%22&limit=1).

Cairn Diagnostics recalled 13C-Spirulina Gastric Emptying Breath Test kits due to the potential for false negative diagnosis of gastroparesis, according to the FDA. The recall was announced on Jan. 8, 2021.

How to tell if you have it

  • Brand: Cairn Diagnostics
  • Product: 13C-Spirulina Gastric Emptying Breath Test (GEBT)
  • Lot Codes: K021-021R, K021-022
  • Quantity: 103 kits

The hazard

Certain GEBT kits containing 13C-Spirulina elicit unusually high 13CO2-excretion rates, which can lead to a false negative diagnosis of gastroparesis.

How to tell if you have this one

Check the lot code on the test kit. Affected kits have lot codes K021-021R or K021-022.

  • Brand
    Cairn Diagnostics
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Code

    Look for lot codes K021-021R or K021-022 on the test kit.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 6 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution in the states of GA, NY, MI, CA, KS, NC.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Georgia, Kansas, Michigan, New York, North Carolina.

Recall timeline

FDA terminated this recall 2.6 years after the firm started it.

1. Firm started the recall: Jan 8, 202112. FDA classified it Class II: Feb 16, 202123. Published in FDA’s Enforcement Report: Feb 24, 202134. FDA terminated the recall: Aug 9, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using this test?

No, but you should check the lot code to ensure you have a recalled version.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1128-2021 (January 8, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1128-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA